Tandem Diabetes Care Inc
NASDAQ:TNDM
Tandem Diabetes Care Inc
Other Current Assets
Tandem Diabetes Care Inc
Other Current Assets Peer Comparison
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
Other Current Assets
$20.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
35%
|
CAGR 10-Years
18%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Other Current Assets
$1.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Current Assets
$991m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
5%
|
|
Stryker Corp
NYSE:SYK
|
Other Current Assets
$986m
|
CAGR 3-Years
19%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-4%
|
|
Abbott Laboratories
NYSE:ABT
|
Other Current Assets
$2.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-6%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Current Assets
$272.9m
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
11%
|
See Also
What is Tandem Diabetes Care Inc's Other Current Assets?
Other Current Assets
20.5m
USD
Based on the financial report for Mar 31, 2024, Tandem Diabetes Care Inc's Other Current Assets amounts to 20.5m USD.
What is Tandem Diabetes Care Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
18%
Over the last year, the Other Current Assets growth was 33%. The average annual Other Current Assets growth rates for Tandem Diabetes Care Inc have been 9% over the past three years , 35% over the past five years , and 18% over the past ten years .